ZKB/CALL/NOVARTIS N/92/0.0714/28.06.24 Share Price

Warrant

NOV7HZ

CH1281033113

Delayed Swiss Exchange 08:50:00 20/06/2024 pm IST
0.16 CHF +6.67% Intraday chart for ZKB/CALL/NOVARTIS N/92/0.0714/28.06.24
Current month+23.08%
1 month-5.88%
Date Price Change
20/24/20 0.16 +6.67%
19/24/19 0.15 +25.00%
18/24/18 0.12 -20.00%

Delayed Quote Swiss Exchange

Last update June 20, 2024 at 08:50 pm IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying NOVARTIS AG
Issuer ZKB
NOV7HZ
ISINCH1281033113
Date issued 04/10/2023
Strike 92 CHF
Maturity 28/06/2024 (3 Days)
Parity 14 : 1
Emission price 0.22 CHF
Emission volume N/A
Settlement Beides
Currency CHF

Technical Indicators

Highest since issue 0.28 CHF
Lowest since issue 0.045 CHF
Spread 0.02 CHF
Spread %12.50%

Company Profile

Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales (excluding discontinued operations) break down by therapeutic area as follows: - oncology (29.9%); - immunology (17.2%); - cardiovascular, renal and metabolic diseases (14.1%); - neuroscience (8.9%). The remaining net sales (29.9%) are from contract manufacturing of pharmaceutical products. At the end of 2023, Novartis AG had 33 production sites worldwide. Net sales are distributed geographically as follows: Europe (33%), the United States (39.5%), Asia/Africa/Australasia (20.5%), Canada and Latin America (7%).
Sector
-
More about the company

Ratings for Novartis AG

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Novartis AG

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
22
Last Close Price
107.2 USD
Average target price
110.3 USD
Spread / Average Target
+2.88%
Consensus
  1. Stock Market
  2. Warrants
  3. NOV7HZ Warrant